News & Media

Stay in the know
News

N2CR Functional Precision Medicine Asia Symposium 2023

20 November 2023

On 14 November 2023, N2CR hosted the N2CR Functional Precision Medicine Asia Symposium 2023 at the MD 11 CRC Auditorium....

Read More →
News

CanCycle 2023 2nd Edition Launch at PAssion Wave East Coast

20 November 2023

Are you ready to CanCycle?! CanCycle 2023 is back for its second iteration. Thank you to all who attended the launch at ...

Read More →
Research News

TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia

11 October 2023

This study, co-led by A/Prof Takaomi Sanda and A/Prof Allen Yeoh, delves into T-cell acute lymphoblastic leukemia (T-ALL...

Read More →
Research News

PI3K/AKT/mTOR signalling transduction pathway and targeted therapies in cancer

11 October 2023

The PI3K/AKT/mTOR (PAM) signaling pathway is crucial in regulating cell survival, growth, and the cell cycle. Its comple...

Read More →
News

N2CR Invited Speaker Series with Dr Sophia Adamia

12 September 2023

N2CR had the honour of having Dr Sophia Adamia, from the Beth Israel Deaconess Medical Center in Boston, visit us on 5 S...

Read More →
News

NUS-Kanagawa Symposium 2023

9 September 2023

On 4th and 5th September 2023, N2CR had the honour of holding the NUS-Kanagawa Symposium 2023,  jointly with CSI Singap...

Read More →
Research News

Understanding Autophagy in Pancreatic Cancer: From Bioinformatics to Clinical Insights

15 August 2023

Pancreatic cancer is a devastating illness with a poor five-year survival rate. A team of researchers, which includes A/...

Read More →
Research News

Possible reasons behind the resistance of certain cancer cells to the chemotherapy drug 5-FU

15 August 2023

5-Fluorouracil (5-FU) is a common chemotherapy drug widely used around the world to treat cancer but development of resi...

Read More →
Research News

Berberine: Fighting Breast Cancer’s Spread through Gut Bacteria & Natural Chemicals

12 July 2023

A team of researchers, led by A/Prof Gautam Sethi from N2CR, conducted a study investigating the therapeutic possibiliti...

Read More →